Pharma Tech Outlook: Pharma Tech Magazine

SONEAS Chemicals: Reliable Chemistry Partner to Pharmaceuticals

Top 10 CMOs in Europe - 2021


The year 2021 is bringing a plethora of advancements into the contract manufacturing organisation (CMO) space, driven by the increasing demand from the pharma organisations. Several factors, including tight timelines, cost-reductions, and quality standards are playing a role in the rapid rise of the CMO space. And to keep up with this evolution, CMOs are also investing in robust technologies to shore up their capabilities.

The integration of technologies like AI, machine learning, and robotic process automation (RPA) are enabling CMOs to streamline much of the repetitive and time-consuming tasks during the production process. CMOs that are on the helm of digitalisation are already integrating these technologies and unlocking the benefits or reduced costs and risks associated with drug manufacturing, while achieving unprecedented levels of efficiency and productivity.

RPA is turning out to be a key factor empowering CMOs to meet the evolving requirements of the pharmaceutical sector. Whether it is automating back-office tasks or process-oriented operations, RPA is becoming a go to technology for CMOs. In addition, it is enabling the organisations to secure approvals at a quicker rate and bring life-saving drugs to the market.

With such innovationsboosting accuracy and efficiency, the pharmaceutical sector is standing at the cusp of the next digital transformation. In order to assist CMOs in shoring up their capabilities with robust technologies and effective solutions, we have compiled this issue of Pharma Tech Outlook. In this edition, we have listed top 10 CMO solution providers to highlight the ones that can help you escalate your chances of success. Equipped with innovative technological capabilities, these enlisted CMO solution providers are transforming the pharmaceutical landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the pharmaceutical sector on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organisation need to foster an environment driven by robust and efficient technology.

We present to you Pharma Tech Outlook’s “Top 10 CMOs in Europe - 2021.”

    Top CMOs in Europe

  • Ardena is a multi-service Contract Development & Manufacturing Organisation (CDMO) assisting small-to-mid sized biopharma companies with services spanning the full development life cycle. The company offers a comprehensive ‘Make, Analyse, File’ model from drug substance and drug product manufacturing, bioanalytical services, through to regulatory dossier development. Headquartered in Belgium, Ardena operates and caters to its clients across several sites in the Netherlands, Sweden, and Latvia. Ardena offers an integrated services platform to reduce the timeline of drug development, from initial idea to first-in-human (FIH) clinical verification. The platform’s make, analyse, and file capabilities to reduce the complexity and risks associated with Phase 1 timelines along with dedicated state-of-art nanomedicine development, analysis, and process capabilities

  • BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006. Innovation is the hallmark of BSP with investments in new technologies and production methods in a high containment plant. The BSP industrial building covers an area of 30,000 m2 in a campus of approximately 20 hectares, 60 km to the south of Rome, ranking it in the world today as one of the most important Contract Development and Manufacturing Organization (CDMOs) for anticancer drugs

  • Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Cambrex offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and highly potent APIs. In addition, Cambrex can support conventional dosage forms including oral solids, semi-solids and liquids and has the expertise to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments

  • Formosa is a CDMO service provider specialising in the development of active pharmaceutical ingredients (APIs) and Antibody Drug Conjugates (ADCs), along with cytotoxic and non-cytotoxic injectables of aseptic liquid filling and lyophilisation. Formosa Laboratories Inc. was founded in 1995 and started with the API business. Today, as an established API manufacturer receiving GMP inspections from regulatory authorities around the globe, the company is well on its way to becoming a world-leading CDMO

  • ICROM is an Italian company specialized in the GMP manufacturing and in contract manufacturing of active pharmaceutical ingredients (APIs) and relevant intermediates. Our classical products belong to antipsychotic area and more recently to the one of high-potency anticancer drugs. ICROM operations are based on a 40 years experience in applying its own technologies as well as the technologies developed by its sister company FAR-CHEMICAL, Inc. to serve worlwide pharmaceutical outsourcing

  • Quotient Sciences—Where science and agility integrate and combine. Cutting through silos across a range of drug development capabilities. Saving precious time and money in getting drugs to patients.Providing tailored services and integrated programs across the entire development pathway, Quotient supports customers accelerate their molecule from candidate selection to commercial supply.Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast

  • SONEAS has helped numerous pharma companies and biotech firms conducting early-stage product development and manufacturing, pre-clinical, or initial clinical activities optimise their product development cycle and improve speed to market. Primarily, the company develops Active Pharmaceutical Ingredient (APIs) and intermediates to ensure clients’ development programs are catered to on time. What is more, SONEAS is renowned for its ability to manufacture APIs at the later stages of the clinical study. The company brings to bear its comprehensive set of capabilities, including R&D facilities, chemistry know-how, large scale metathesis production capabilities, quality assurance and control, regulatory compliance, and process innovation, to get the obstacles out of the way of its clients’ operations

  • Founded in 1936, Uquifa carries a long and successful legacy of producing high-quality active pharmaceutical ingredients (APIs) and intermediates that are 100 percent compliant against many international regulations. The company today maintains several fully-certified facilities in Mexico, Spain, and Hungary, allowing it to offer low operational and overhead costs for all its patrons. Uquifa practices the application of agile methodologies to help overcome various barriers or constraints, effectuating a lean and efficient manufacturing culture. The company also leverages integrated project teams for a very collaborative approach towards production—not only internally but also its customers



    All development and manufacturing activities are supported by highly skilled R&D technical centres, strong and state of the art analytical services including solid form and QBD laboratories. MINAKEM’s talented team also ensures high-quality services in Quality Assurance, Regulatory Affairs, Safety, Health and Environment (SHE). Minakem is a technology-driven company with expertise in complex multi-step synthesis, pressure chemistry, chiral synthesis, halogenation chemistry, steroid chemistry and “prazole” chemistry. Strong synergies within MINAKEM facilities sites offer customers the flexibility, responsiveness and cost-effectiveness paired with the strong technical know-how to create significant added value within our customers’ supply chains

  • Produlab Pharma

    Produlab Pharma

    Produlab Pharma, situated at Raamsdonksveer in the Netherlands, is an independent Pharmaceutical company, that set out to produce veterinary pharmaceuticals from its foundation in 1991. Produlab Pharma is equipped with ultramodern production facilities complying with the strictest quality standards. Production and packaging are carried out in accordance with the Guidelines for Good Manufacturing Practice (GMP). From development till finished Product, Produlab can assist their customers from beginning till the finished Product